Company: SONM
Filing Date: 2025-07-09
Form Type: S-3
Source: 0001641172-25-018394
Chunk: 10

Company: SONIM TECHNOLOGIES INC
Filing Date: 2025-07-09
Form: S-3
Chunk 10
---
 II—Item 1A—Risk Factors” in our most recent Quarterly Report on Form 10-Q filed subsequent to such Form 10-K that are incorporated herein by reference, as may be amended, supplemented or superseded from time to time by other reports we file with the SEC in the future. The risks and uncertainties we have described are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our operations. If any of these risks actually occur, our business, financial condition, results of operations, or cash flow could be seriously harmed. This could cause the trading price of our common stock to decline, resulting in a loss of all or part of your investment. Please also read carefully the section above titled “ Cautionary Note Regarding Forward-Looking Statements” and the identically titled sections of our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q or Current Reports on Form 8-K.

| 7 |

<div align='center'>USE OF PROCEEDS</div>

We will not receive any proceeds from the sale of the Resale Shares by the Selling Stockholders.

We will receive proceeds from
the cash exercise of the Warrants, which, if exercised for cash with respect to all of the 550,000 shares of common stock underlying
such Warrants at the exercise price per share of $1.3864, would result in gross proceeds to us of approximately $0.76 million.
We intend to use any net proceeds from the cash exercise of the Warrants for general corporate purposes. There can be no assurance that
any of the Warrants will be exercised by the Selling Stockholders. Currently, the Warrants cannot be exercised on a cashless basis,
however, there can be no assurance that the terms of the Warrants will not be amended in the future to permit the Warrants to be exercised
on a cashless basis. If the Warrants (as amended to permit the cashless exercise of the Warrants) are exercised in a cashless exercise,
we will not receive any proceeds from the exercise of the Warrants.

The Selling Stockholders
will receive all of the net proceeds from the sale of the Resale Shares under this prospectus. The Selling Stockholders will pay
any underwriting, broker-dealer or agent discounts, concessions and commissions, and expenses incurred by the Selling Stockholders
for accounting, tax, and legal services and any other expenses incurred by the Selling